Explore Cepheid’s advanced #MolecularDiagnostics at ECC Conference 2025 — fast, accurate #PCR solutions. Visit us at Booth #11 from 15–17 September to discuss how #GeneXpert can improve patient management in urgent care settings. Learn more: https://t.co/mZ11H2gj9Y

Longer hospital stays, reduced patient functionality, and lost productivity all add pressure to our healthcare system. Dr. Paul Griffin, Director of ID at Mater Health Services on the urgency & cost-effectiveness of timely #moleculardiagnostics #Respiratory using #PCR

Cepheid is pleased to announce Health Canada Licence for Xpert® HCV VL Fingerstick. Read more! https://t.co/Frd1euoaCz

Join us at the 46th Annual #NZSHS 2025 Conference! Stop by Booth #07 on 16 August to explore #Cepheid advanced #MolecularDiagnostics, featuring fast, accurate solutions across #SexualHealth #WomensHealth #Virology #PCR #GeneXpert #POC #PointofCare https://t.co/1A4KpejbD4

Dr. Paul Griffin, Director of Infectious Diseases at Mater Health Services in Brisbane, has voiced significant concerns about the 2025 respiratory season in Australia, particularly regarding the surge in #influenza, #RSV, and #COVID-19 cases. https://t.co/HXpNlvUKMP

NACIQI, the federal committee that oversees accreditors, was meant to meet in July. Their meeting was pushed back twice, now scheduled for December thanks to the shutdown. ACTA's Kyle Beltramini explains how accreditation will change under the Trump administration in IHE 👇

Hepatitis C is a silent epidemic in the U.S., but this small clinic is proving it doesn't have to be

🦠 Antimicrobial and Diagnostic Stewardship: What to know and why it matters for your hospital or healthcare system. 📑 Access the Frost & Sullivan Visual Whitepaper now: https://t.co/Zc0mPvZjVl

Be part of the conversation at our Cepheid’s upcoming Symposium! Don’t miss this opportunity to engage with leaders in the field on Thursday, 19th June at #POC25 https://t.co/FEEGzOEtlR #PointOfCareTesting #Conference #POC

Learn what’s happening in AI and how you can leverage it. Get insights from Amjad Masad, Marc Benioff, Aravind Srinivas, Aaron Levie, and more.

At APIC 2025, learn how #PCR testing from Cepheid can help support antimicrobial stewardship efforts with speed, accuracy, and flexibility. #PCR #antimicrobialstewardship #infectiousdiseases https://t.co/Be8aCyldpD

At APIC 2025, learn how #PCR testing from Cepheid can help support antimicrobial stewardship efforts with speed, accuracy, and flexibility. #PCR #antimicrobialstewardship #infectiousdiseases https://t.co/NfNBO3freL

🚨 Big news in the fight to #EndHepC in the United States! Sens. Cassidy (R-LA) & Van Hollen (D-MD) just introduced the Cure Hepatitis C Act—expanding testing & curative treatment to save 24K lives and $18B over 10 years. #PublicHealth #EndHepatitisC

💡 In-house #PCR testing: Clinical leaders explore the ripple effects on patient care, financial health, and the workforce. 📑 Read more: https://t.co/dX6ABh5h8s

New on The Learning Curve, Jack Johnson Pannell sits down to discuss the lasting value of a liberal arts education, the importance of civic and moral formation, and how grounding students in rigorous curricula builds strong thinkers and citizens. Listen below!

📰 Breaking News! Cepheid Receives Health Canada Licence for Xpert® HIV-1 Viral Load XC Next-Generation Molecular Test for Monitoring Viral Load and HIV-1 Infection. #MolecularDiagnostics #HIV 📢 Read more: https://t.co/owt2Y5dJ3T

🏥 Discover how decentralized diagnostics in the U.K. can positively transform healthcare delivery through improved patient outcomes, alleviate pressure on hospital services and contribute to the success of the government’s 10-year health plan: https://t.co/b2Ss3ocY2V

🧬What's the difference between PCR and antigen testing? Check out this helpful infographic on Cepheid's Insight Hub for a detailed explanation: https://t.co/NuVhgV4z0o

Cepheid and Oxford Nanopore Technologies Partner to Advance Automated Sequencing-Based Solutions Read the full press release: https://t.co/y1Bw4HJDN0

SICK OF ENDLESS DOOM SCROLLING? Dive into the latest page-turner from NYT bestselling author Christopher Greyson! Clear your schedule, this action-packed thriller will grab you and won’t let go. Buckle up for the ride of your life!

Cervical cancer is the fourth most common cancer in women, with around 660,000 new cases in 2022.* Cervical cancer can be easily prevented through vaccination against HPV and regular screening. #HPV #WomensHealth #SexualHealth * https://t.co/JQBZORr0Hf

The ED team of the Martha-Maria Halle-Dölau Hospital in Germany implemented the GeneXpert® system for respiratory and MRSA testing to access on-demand, lab-quality PCR results 24/7. Find out how this positively impacts patient triage in their ED: https://t.co/riDEzrDfQe

Next up in our celebration of more than 20 years of innovation at Cepheid is our GeneXpert® Infinity family of systems. This platform enables maximum flexibility in testing, system placement, staffing, and menu availability.

Our resident expert authored this piece on the emerging threat of invasive Group A Strep. So, what do you need to know? Read more on Cepheid’s Insight Hub > https://t.co/lwCHayM01H

Revisiting Dia al-Azzawi's tapestry tribute to Sabra and Shatila https://t.co/TxV2o2CDud